Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Filings indexed 988 across all filing types
Latest filing 2025-08-21 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT' for the six months ended June 30, 2025. It contains comprehensive unaudited interim condensed consolidated financial statements, including the statement of profit or loss, statement of comprehensive income, and statement of financial position, along with detailed notes to the financial statements. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-08-21 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-08 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 75% confidence The document is a formal announcement of a scheduled board meeting to consider and approve interim results, filed on HKEX. It does not contain the interim results themselves (so it is not an Interim Report IR) nor does it announce any change in directors or management (so it is not MANG), nor does it actually publish a report (so it is not RPA). It is a general regulatory announcement and thus best fits the fallback category Regulatory Filings (RNS).
2025-08-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings Classification · 90% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” under Chapter 19B of the Listing Rules, detailing share capital movements, issued/treasury shares, and related arrangements for the period ended 31 July 2025. It is a routine regulatory submission to the Exchange rather than an annual or interim report, earnings release, capital financing announcement, or other specialized document. It does not announce publication of another report but is itself a mandatory regulatory filing. Therefore it best fits the “Regulatory Filings” category.
2025-08-06 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-08-01 English
INSIDE INFORMATION ANNOUNCEMENT REGARDING THE ESTIMATE FOR INTERIM RESULTS OF 2025
Earnings Release Classification · 92% confidence The document is an announcement made under HKEX Listing Rules and Inside Information Provisions providing a preliminary estimate of the Group’s interim (half-year) 2025 results (revenue, net profit, EPS and non-IFRS measures). It contains key financial highlights only, is unaudited, and expressly states that the formal interim report will be published later. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results with highlights only). It is not the full interim report (IR), nor merely a notice of publication (RPA), so ER is the appropriate classification. H1 2025
2025-07-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.